Skip to main content
. 2023 Jan 25;13:1061641. doi: 10.3389/fonc.2023.1061641

Table 2.

Cancer types reported by current sample.

Total Sample
N=298
n (%)
Breast 75 (25.2%)
Prostate 48 (16.1%)
Cervical 45 (15.1%)
Melanoma 29 (9.7%)
Kidney 26 (8.7%)
Lung 21 (7.0%)
Endometrial/Uterine 16 (5.4%)
Colon or Rectal 20 (6.7%)
Leukemia 18 (6.0%)
Head & Neck 18 (6.0%)
Thyroid 15 (5.0%)
Bladder 14 (4.7%)
Ovarian 10 (3.4%)
Non-Hodgkin’s Lymphoma 8 (2.7%)
Liver 8 (2.7%)
Bone 3 (1.0%)
Other 11 (3.7%)
Multiple 48 (16.1%)

Counts and percentages do not add up to 298 and 100, respectively, due to reported multiple cancers.